RAIDEN RESOURCES LIMITED — Interim / Quarterly Report 2005

Oct 23, 2005

Notes for the Appendix 4C Quarterly Cash Statement for 30 September 2005

MEDICAL MONITORS LIMITED (the "Company")

During the quarter, Company received part payment of \$AUD 255,000 in sales revenue for newly manufactured devices ordered for the USA-based monitoring service, iCardia Healthcare Corporation, through the distributor Primedical International (Primedical). A repayment of AUD\$100,000 has also been received from 'loans outstanding' from overseas entities.

As previously announced, the first order of 5,000 suPER™ ECG monitoring units has been delivered to Chicago, with over 2,500 units having now been activated for the monitoring of cardiac patients. Primedical has informed the Directors of the Company that the suPER^™ has been very well received into the US market.

A second production run of 15,000 units (of the 30,000 currently on order) has now been completed and all have been shipped to the USA. Further progressive payments are expected (to a total of AUD \$750,000) during the coming quarter. In addition, payment for USA technical support and research and development costs for the international business are also anticipated from Primedical.

The Directors believe that sufficient funds, and other financial arrangements, are in place to provide for the payment of accounts as and when they fall due. The Directors further believe that there is a sound financial base for the Company to continue with its current programs, in Australia and overseas, and that the Company will benefit from the increasing sales revenue (and royalty stream) anticipated over the coming months.

The Directors are confident of the continuing success for the Company's products and services in Australia and internationally, and will keep the market informed of any new developments.

Dr Allan Shell Managing Director

Medical Monitors Limited Suite 407 Office Tower Westfield Eastgardens Eastgardens NSW 2036 Australia Tel 02 9344 8100 Fax 02 9344 8200 www.medmon.com.au

Rule 4.7B

Appendix 4C

Quarterly report for entities admitted on the basis of commitments

Introduced31/3/2000.Amended30/9/2001

Name of entity

Medical Monitors Limited

ABN

68 009 161 522

Month ended in current quarter

30 September 2005

Consolidated statement of cash flows

	Cash flows related to operating activities	Current Quarter \$A'000	Year to date $(3$ months)
			SA'000
1.1	Receipts from customers	279	279.
1.2	Payments for (a) staff costs (b) advertising and marketing (c) research and development	(100)	(100)
	(d) leased assets
	(e) other working capital	(505)	(505)
1.3	Dividends received
1.4	Interest and other items of a similar nature received
1.5	Interest and other costs of finance paid
1.6	Income taxes paid
1.7	Other (Govt Grants)
	Other (GST Refund)	40.	40
	Other (Insurance Refund)
	Net operating cash flows	(286)	(286)

⁺ See chapter 19 for defined terms.

		Current Quarter \$A'000	Year to date (3 months) \$A'000
1.8	Net operating eash flows (carried forward)	(286)	(286)
1.9	Cash flows related to investing activities Payment for acquisition of: (a) businesses (item 5) (b) equity investments (c) intellectual property (d) physical non- currentassets
1.10	(e) other non-current assets Proceeds from disposal of: $(a)$ businesses (item 5)
	(b)equity investments (c) intellectual property (d) physicalnon- currentassets (e) other non-current assets
1.11 1.12 1.13	Loans to other entities Loans repaid by other entities Other (provide details if material)	(227) 110	(227) 110
	Net investing cash flows	(117)	(117)
1.14	Total operating and investing cash flows	(403)	(403)
1.15 1.16 1.17 1.18 1.19 1.20	Cash flows related to financing activities Proceeds from issues of shares, options, etc. Proceeds from sale of forfeited shares Proceeds from borrowings Repayment of borrowings Dividends paid Other (Security Deposit) Net financing cash flows	250 180 430	250 180 430
	Net increase (decrease) in cash held	27	27
1.21 1.22	Cash at beginning of quarter/year to date Exchange rate adjustments to item 1.20	203	203
1.23	Cash at end of quarter/month	230	230

⁺ See chapter 19 for defined terms.

Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the relatedentities

		Current Month SA'000
1.24	Aggregate amount of payments to the parties included in item 1.2	8
1.25	Aggregate amount of loans to the parties included in item 1.11
1.26	Explanation necessary for an understanding of the transactions

Consultancy fees paid to research entities controlled by directors.

Non-cash financing and investing activities

• $2.1$ Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows
• $2.2$ Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

Financingfacilities available

Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).

		Amount available \$A'000	Amountused \$A'000
3.1	Loan facilities
3.2	Credit standby arrangements	1.000	nil

⁺ See chapter 19 for defined terms.

Reconciliation of cash

Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows.		Current Quarter \$A'000	Previous quarter \$A'000
4.1	Cash on hand and at bank	230	203
4.2	Deposits at call
4.3	Bank overdraft.
4.4	Other (provide details)
	Total: cash at end of quarter (item $1.22$ )	230	203

Acquisitions and disposals of business entities

		Acquisitions (Item 1.9(a))	Disposals (Item 1.10(a))
5.1	Name of entity
5.2	Place of incorporation or registration
5.3	Consideration for acquisition or disposal
5.4	Total net assets
5.5	Nature of business

Compliance statement

• $\mathbf{1}$ This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.
• $\overline{2}$ This statement does give a true and fair view of the matters disclosed.

(Director)

Sign here:

Date: 24^th October 2005

Dr Allan Shell Print name:

⁺ See chapter 19 for defined terms.

Notes

• $1¹$ The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.
• $2.$ The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this report except for the paragraphs of the Standard set out below.
• $\bullet$ 6.2 - reconciliation of cash flows arising from operating activities to operating profit or loss
• $9.2$ - itemised disclosure relating to acquisitions
• 9.4 - itemised disclosure relating to disposals
• $12.1(a)$ policy for classification of cash items
• disclosure of restrictions on use of cash $12.3$
• 13.1 - comparative information
• $\overline{3}$ . Accounting Standards. ASX will accept, for example, the use of International Accounting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.

$+$ See chapter 19 for defined terms.